Oral formulations of salts of isophosphoramide mustard and its analogs and their use in the treatment of a condition characterised by abnormal cell growth or differentiation (such as cancer)
Disclosed are oral formulations of the isophosphoramide mustard derivatives of Formula (E), additionally comprising lubricant, diluent and disintegrant. Also disclosed is the use of the oral formulation of isophosphoramide mustard derivatives of Formula (E) for treating a condition characterised by abnormal cell growth or differentiation (such as cancer).